Home Tags Vaccines

Tag: Vaccines

La vacuna de Pfizer contra la COVID parece promisoria

One-Third of U.S. Adults Likely to Refuse a COVID-19 Vaccine

Blacks, women, and conservatives more hesitant in the United States

HealthDay Reports: Evidence Mounts That TB Vaccine Might Help Protect Against COVID-19

Two Billion COVID-19 Vaccine Doses From BioNTech Expected This Year

Company also looking to widen eligibility for the vaccine to include pregnant women, children, and others

HealthDay Reports: Plan in Place to Up Production of Prefilled Syringes for Future COVID-19 Vaccine

Vaccine Rollout Slows as Many Health Care Workers Balk at Shots

In nursing homes and to some degree in hospitals, employees are refusing shots, expressing fears of side effects

Could the TB Vaccine Help Prevent COVID-19?

11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported

Median interval from vaccine receipt to symptom onset was 13 minutes

WHO: Remdesivir Not Advised for Hospitalized COVID-19 Patients

U.K. Is First Country to Approve Oxford-AstraZeneca COVID-19 Vaccine

Vaccine could become the dominant form of inoculation because at $3 to $4 a dose, it is a fraction of the cost of other vaccines

Maybel Jong and Dr David Shulkin

HD Live! Takes a Look Back at Pandemic’s Progression

David Shulkin, M.D., and Joel Zivot, M.D., discuss handling of pandemic, overcoming vaccine hesitancy

La vacuna de Pfizer contra la COVID parece promisoria

Majority Do Not Support COVID-19 Vaccine Mandates for Adults

Employer mandates deemed more acceptable than state mandates

For Spanish Translation

FDA Issues EUA for Moderna COVID-19 Vaccine

On Sunday, ACIP voted to recommend frontline workers and those ages 75 years and older be included in next phase of vaccine distribution

Low U.S. Flu Rates Seen as Pandemic Rages

Many more people are getting flu shots to avoid the risk for getting both the flu and COVID-19

12/18 -- Most Americans Opposed to 'COVID Vaccine Mandates'

Advisory Committee Votes to Recommend EUA for Moderna Vaccine

Could become the second COVID-19 vaccine in a week to receive emergency use authorization